MAPK8 and neoplasm: Administered to rats the JNK inhibitor SP600125 suppresses chemically induced hepatocarcinogenesis by shifting phosphorylation from the oncogenic pSmad3L signaling to the tumor-suppressive pSmad3C pathway [33].